Live
AgilentAgilent Showcases Integrated Mass Spectrometry and Chromatography Solutions at ASMS 2026 - the-scientist.comEndpoints NewsGrace Science says FDA bottleneck jeopardizes rare disease therapyClinical OMICsDigital Pathology and the NHS: Overcoming Barriers to a More Connected FutureFierceBiotechFueled by M&A and partnerships, biotech is poised for continued growth: EYFierceBiotechGalmed acquires Colospan in $4.5M deal as it eyes $6B GI dx marketBioPharma DiveMerck, Gilead report mixed outcomes in key lung cancer, HIV studiesEndpoints NewsA different approach to lowering healthcare costsCellmRNA 3′ UTRs chaperone intrinsically disordered regions to control protein activityClinical OMICsBeyond the Genome: Five Emerging Leaders in Epigenetics DiagnosticsBioPharma DiveStealthy startup Treeline plans a reverse merger10x Genomics Blog10x Genomics Acquires Proteintech Genomics to Expand Single-Cell Proteomics Portfolio - citybizEndpoints NewsHow K Health moved AI chatbots into hospitals
FierceBiotech 25 avr. 2026

Thermo Fisher sees higher Q1 earnings amid strong biopharma demand

Thermo Fisher sees higher Q1 earnings amid strong biopharma demand

Original
Contenu indisponible. Consultez la source originale.